Onkologie. 2011:5(3):175-180

Multiple cancers of nervous system and other primary neoplasms

Edvard Geryk1, Jiří Kozel2, Radim Štampach2, Dalibor Pacík1, Petr Dítě1, Petr Kubíček2, Milan Konečný2
1 Fakultní nemocnice Brno
2 Geografický ústav Přírodovědecké fakulty Masarykovy univerzity Brno

The number of malignant neoplasms of central nervous system (MN CNS), based in the Czech Cancer Registry, reached 26,548 diseases,

of which there were 14,263 (53.7 %) of males and 12,285 (46.3 %) of females in 1959–2008, presented 412 (8.1 per 100,000 males) and

418 (7.9 per 100,000 females) diseases in 2008. Their prevalence increased from 1,169 to 2,565 survived cases between 1989–2005, with

3,430 cases expected in 2015. A total of 962 registered multiple MN CNS there were 150 primary diseases in males and 162 in females,

327 subsequent MN CNS in males and 323 in females, i. e. 5.1 % in males and 6.2 % in females of all newly registered MN CNS in period

1976–2005. In this period the number of primary cases increased twice, of subsequent ones nearly 30 times during five periods. The

primary and subsequent MN CNS prevailed in the age group till 49 years in females over males, in the age group 50–69 years in males

over females. A total of 14 Czech regions there were distributed 47 % of all multiple MN CNS in the four regions (Northern and Southern

Moravia, Prague, Central Bohemia).

Only 6.2 % multiplicities were registered in early and 7.4 % in advanced clinical stages; 86.4 % stages were unregistered. The average

interval between 150 primary MN CNS and 170 other subsequent neoplasms was five years in males, between 162 primary and 170 subsequent

cases six years in females, of which the most frequent were following digestive and skin carcinomas in both sex. In 327 subsequent

MN CNS preceded 390 primary cancers in males, in 323 subsequent were 362 primary cases in females, of which the most frequent were

carcinomas of skin, female genital and breast, prostate and digestive tract. A total of 962 multiple MN CNS there were only 91 survived

and 871 death patients up to analysis in October 2007 with predominance of surviving females over males.

Keywords: cancers of nervous system, incidence, prevalence, multiple cancers, primary and subsequent neoplasms

Published: July 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geryk E, Kozel J, Štampach R, Pacík D, Dítě P, Kubíček P, Konečný M. Multiple cancers of nervous system and other primary neoplasms. Onkologie. 2011;5(3):175-180.
Download citation

References

  1. Boyle P, Smans M. Atlas of cancer mortality in the European Union and the European Economic Area, 1993-1997. Lyon: IARC, Sci Publ No. 2008: 159.
  2. Lonn S, Klaeboe L, Hall P, et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer 2004; 108: 450-455. Go to original source... Go to PubMed...
  3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. Cancer J Clin, 2007; 57: 43-66.
  4. Fisher JL, Schwartzbaum JA, Wrensch M, et al. Epidemiology of brain tumors. Neurol Clin 2007; 25: 867-890. Go to original source... Go to PubMed...
  5. Filippini G, Maisonneuve P, McCredie M, et al. Relation of childhood brain tumors to exposure of parents and children to tobacco smoke: the SEARCH international case control study. Surveillance of Environmental Aspects Related to Cancer in Humans. Int J Cancer 2002; 100: 206-213. Go to original source... Go to PubMed...
  6. Bhatia S, Sather HN, Pabustan OB, et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002; 99(12): 4257-4264. Go to original source... Go to PubMed...
  7. Karlsson P, Holmberg E, et al. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res 1998; 150(3): 357-364. Go to original source...
  8. NRC. Health effects of exposure to low levels of ionizing radiation. National Research Council, BEIR V. Washington: National Academy Press, 1990.
  9. Cristy M. Acive bone marrow distribution as a function of age in humans. Phys Med Biol 1981; 26(3): 389-400. Go to original source... Go to PubMed...
  10. Duffner PK, Krischer JP, et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a pediatric oncology group study. Ann Neurol 1998; 44(3): 313-316. Go to original source... Go to PubMed...
  11. Goldstein A M, Yuen J, et al. Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control 1997; 8(6): 865-8714. Go to original source... Go to PubMed...
  12. Kleihues P, Cavenee W K (eds). Patology and genetics of tumor sof the nervous system. Lyon: IARC, 1997.
  13. Schoenberg BS, Christine BW, et al. Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 1975; 25(8): 705-712. Go to original source... Go to PubMed...
  14. Malmer B, Tavelin B, et al. Primary brain tumours as second primary: a novel association between meingioma and colorectal cancer. Int J Cancer 2000; 85(1): 78-81. Go to original source... Go to PubMed...
  15. Custer BS, Koepsell TD, et al. The asssociation between breast carcinoma and meningioma in women. Cancer 2002; 94(6): 1626-1635. Go to original source...
  16. Vasen H F, Sanders EA, Taal BG, et al. The risk of brain tumors in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer 1996; 65(4): 422-425. Go to original source... Go to PubMed...
  17. Salminen E, Pukkala E, et al. Second cancers in patients with brain tumours - impact of treatment. Eur J Cancer 1999; 35(1): 102-105. Go to original source... Go to PubMed...
  18. Paunu N, Pukkala E, et al. Cancer incidence in families with multiple glioma patients. Int J Cancer 2002; 97(6): 819-822. Go to original source... Go to PubMed...
  19. Geryk E, Dítě P, Pešek M, a kol. Následné primární novotvary u 125 262 onkologicky nemocných v České republice 1976-2005. Onkologie 2009; 3(3): 181-189.
  20. ÚZIS: Novotvary ČR. Ediční řada Zdravotnická statistika, ÚZIS ČR, 1977-2011, www.uzis.cz.
  21. Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of tumor sof the central nervous system. Lyon: IARC, 2007.
  22. Geryk E, Dítě P, Trna J, a kol. Zátěž nádory pankreatu u české populace. Onkologie 2010; 4(5): 322-325.
  23. Geryk E, Dítě P, Kozel J, a kol. Další primární novotvary u nemocných s karcinomem prostaty ve srovnání s jeho incidencí, mortalitou a prevalencí. Onkologie 2010; 4(2): 89-93.
  24. Geryk E, Dítě P, Pacík D, a kol. Zátěž české populace nádory v urologii, 1959-2007. Urologie pro praxi 2010; 11(5): 273-277.
  25. Geryk E, Bendová M, a kol. Karcinom prsu a následné primární zhoubné novotvary v České republice, 1976-2005. Onkologie 2009; 3(1): 54-61.
  26. Dítě P, Geryk E. Trend of primary and subsequent cancers of the gastrointestinal tract in the Czech population, 1976-2005. Digestive Dis 2010; 28: 657-669. Go to original source... Go to PubMed...
  27. Geryk E, Dítě P, Sedláková L, a kol. Trend vícečetných nemelanomových nádorů kůže z pohledu jejich epidemiologie. Dermatologie pro praxi 2010; 4(1): 5-9.
  28. ACS. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; Sci Publ. No. 500 809, 2009: 24-41.
  29. Weiss J. Příspěvek ke statistikám o přibývání rakoviny. Prakt. Lék. 1933; 22: 617.
  30. Geryk E, Dítě P, Trna J, a kol. Klinická stadia u nemocných s vícečetnými novotvary. Onkologie, 2010; 4(6): 357-361.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.